| Authors: |
Samala R; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 South Coulter Drive, Amarillo, Texas, 79106, USA., Thorsheim HR; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 South Coulter Drive, Amarillo, Texas, 79106, USA., Goda S; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 South Coulter Drive, Amarillo, Texas, 79106, USA.; Formurex, Inc., Stockton, California, 95215, USA., Taskar K; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 South Coulter Drive, Amarillo, Texas, 79106, USA.; Mechanistic Safety and Disposition, IVIVT, GlaxoSmithKline, Ware, Hertfordshire, SG12 0DP, UK., Gril B; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, 20892, USA., Steeg PS; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, 20892, USA., Smith QR; Department of Pharmaceutical Sciences, School of Pharmacy, Texas Tech University Health Sciences Center, 1300 South Coulter Drive, Amarillo, Texas, 79106, USA. quentin.smith@ttuhsc.edu. |